Analysen von Emily Field
| 21.06.23 | Bayer Overweight | Barclays Capital | |
| 15.06.23 | Novartis Underweight | Barclays Capital | |
| 06.06.23 | Merck Overweight | Barclays Capital | |
| 05.06.23 | GSK Equal Weight | Barclays Capital | |
| 05.06.23 | Roche Equal Weight | Barclays Capital | |
| 05.06.23 | AstraZeneca Overweight | Barclays Capital | |
| 05.06.23 | Novartis Underweight | Barclays Capital | |
| 25.05.23 | Bayer Overweight | Barclays Capital | |
|
Werbung
|
|||
| 24.05.23 | Roche Equal Weight | Barclays Capital | |
| 23.05.23 | Novo Nordisk Overweight | Barclays Capital | |
| 23.05.23 | Sanofi Overweight | Barclays Capital | |
| 15.05.23 | Merck Overweight | Barclays Capital | |
| 12.05.23 | Bayer Overweight | Barclays Capital | |
| 11.05.23 | Merck Overweight | Barclays Capital | |
| 02.05.23 | Merck Overweight | Barclays Capital | |
| 26.04.23 | Novartis Underweight | Barclays Capital | |
| 25.04.23 | Bayer Overweight | Barclays Capital | |
| 20.04.23 | Novo Nordisk Overweight | Barclays Capital | |
| 14.04.23 | Novo Nordisk Overweight | Barclays Capital | |
| 13.04.23 | Merck Overweight | Barclays Capital | |
| 12.04.23 | AstraZeneca Overweight | Barclays Capital | |
| 12.04.23 | Novo Nordisk Overweight | Barclays Capital | |
| 11.04.23 | Novartis Underweight | Barclays Capital | |
| 27.03.23 | Roche Equal Weight | Barclays Capital | |
| 27.03.23 | Sanofi Overweight | Barclays Capital | |
| 28.02.23 | Bayer Overweight | Barclays Capital | |
| 09.02.23 | Bayer Overweight | Barclays Capital | |
| 25.01.23 | AstraZeneca Overweight | Barclays Capital | |
| 25.01.23 | Roche Overweight | Barclays Capital | |
| 25.01.23 | Sanofi Equal Weight | Barclays Capital | |
| 25.01.23 | GSK Equal Weight | Barclays Capital | |
| 25.01.23 | Bayer Overweight | Barclays Capital | |
| 25.01.23 | Merck Overweight | Barclays Capital | |
| 25.01.23 | Novartis Underweight | Barclays Capital | |
| 25.01.23 | Novo Nordisk Overweight | Barclays Capital | |
| 11.01.23 | Bayer Overweight | Barclays Capital | |
| 10.01.23 | Bayer Overweight | Barclays Capital | |
| 09.01.23 | GSK Equal Weight | Barclays Capital | |
| 09.01.23 | Novo Nordisk Overweight | Barclays Capital | |
| 09.01.23 | AstraZeneca Overweight | Barclays Capital | |
| 23.12.22 | AstraZeneca Overweight | Barclays Capital | |
| 23.12.22 | GSK Equal Weight | Barclays Capital | |
| 23.12.22 | Sanofi Equal Weight | Barclays Capital | |
| 23.12.22 | Novo Nordisk Overweight | Barclays Capital | |
| 23.12.22 | Novartis Underweight | Barclays Capital | |
| 23.12.22 | Merck Overweight | Barclays Capital | |
| 23.12.22 | Roche Overweight | Barclays Capital | |
| 23.12.22 | Bayer Overweight | Barclays Capital | |
| 12.12.22 | Sanofi Equal Weight | Barclays Capital | |
| 30.11.22 | Sanofi Equal Weight | Barclays Capital | |